Chinese ophthalmology firm Arctic Vision snags over $100m in Series B round

Chinese ophthalmology firm Arctic Vision snags over $100m in Series B round

Source: Marina Vitale/Unsplash

Arctic Vision, a China-based clinical-stage ophthalmology company developing innovative therapies for pan-ocular diseases, Tuesday announced the completion of over $100 million in a Series B funding round led by private equity (PE) firm Loyal Valley Capital.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter